Korean J Dermatol.
2012 Nov;50(11):931-936.
Experience in 102 Non-melanoma Skin Cancer with Mohs Micrographic Surgery
- Affiliations
-
- 1Department of Dermatology, Inha University School of Medicine, Incheon, Korea. dmhjsong@naver.com
- 2Oracle Clinic, Korea.
- 3Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Abstract
- BACKGROUND
Mohs micrographic surgery (MMS) is a specialized type of minimal marginal surgery, which offers superior cure rates to other options in the treatment of non-melanoma skin cancers.
OBJECTIVE
The aim of this study is to investigate the clinical characteristics and recurrence rate of the non-melanoma skin cancer and to estimate the safeties of MMS.
METHODS
We retrospectively evaluated 102 patients who had been diagnosed with non-melanoma skin cancer and treated by MMS from May 2008 to September 2011.
RESULTS
The most common cancer was basal cell carcinoma (63.72%), followed by squamous cell carcinoma (31.38%). The local flap was the most common method to repair surgical defects (74.5%), followed by primary closure (17.64%). Cervical lymph node metastasis was confirmed in 1 case (0.98%). Recurrence after MMS was observed in 1 of 102 patients (0.98%).
CONCLUSION
MMS is a safe method for the treatment of non-melanoma skin cancer.